On Invalid Date, Virios Therapeutics (NASDAQ: VIRI) reported Q2 2023 earnings per share (EPS) of -$0.08, up 81.82% year over year. Total Virios Therapeutics earnings for the quarter were -$1.44 million. In the same quarter last year, Virios Therapeutics's earnings per share (EPS) was -$0.44.
As of Q4 2023, Virios Therapeutics's earnings has grown year over year. Virios Therapeutics's earnings in the past year totalled -$7.58 million.
What is VIRI's earnings date?
Virios Therapeutics's earnings date is Invalid Date. Add VIRI to your watchlist to be reminded of VIRI's next earnings announcement.
What was VIRI's revenue last quarter?
On Invalid Date, Virios Therapeutics (NASDAQ: VIRI) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Virios Therapeutics's revenue was $0.00.
What was VIRI's revenue growth in the past year?
As of Q4 2023, Virios Therapeutics's revenue has grown null year over year. Virios Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.